Tort Reform Needed To Relieve “Chronic Pain” Of Litigation, GSK Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Legal costs within the pharmaceutical industry are becoming a "chronic pain" that can only be addressed through comprehensive tort reform, GlaxoSmithKline CEO J.P. Garnier said July 27.